MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Immune Design Corp Company Profile (NASDAQ:IMDZ)

Consensus Ratings for Immune Design Corp (NASDAQ:IMDZ) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $28.00 (35.59% upside)

Analysts' Ratings History for Immune Design Corp (NASDAQ:IMDZ)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2015Jefferies GroupReiterated RatingBuy$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015Jefferies GroupUpgradeHold -> Buy$32.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014Jefferies GroupDowngradeBuy -> Hold$15.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Leerink SwannInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Wells Fargo & Co.Initiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2014Jefferies GroupInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)